Corrigendum to “Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt” [Biomed. Pharmacother. 199 (2026) 119387] - 03/06/26

Eetu Valkama ^{a, ⁎} , Elisa Toropainen ^a, Simar Pal Singh ^b, Annika Valtari ^a, Ali Koskela ^a, Arto Merivaara ^a, Oswaldo Perez ^c, Marika Ruponen ^a, John Groten ^b, Nicolaas Schipper ^c, Arto Urtti ^a, Kati-Sisko Vellonen ^a, Tatu Lajunen ^a, Jooseppi Puranen ^a

^a University of Eastern Finland - Kuopio Campus, Kuopio, Finland 

^b PamGene International BV, the Netherlands 

^c RISE Research Institutes Of Sweden, Sweden 

^⁎ Corresponding author.

Le texte complet de cet article est disponible en PDF.